Why Tubal Ligation Cuts Ovarian Cancer Risk by 64%

The most common complication is urinary issues, in about one or two out of every hundred patients we operate on, because we try carefully to identify and spare the inferior hypogastric nerve. Unlike axillary lymph node dissection, we don't see lymphoedema with the same frequency after pelvic lymph node dissection. We also follow the ERAS protocol, enhanced recovery after surgery, ambulating the patient the same day and starting oral intake within hours.

PCOS is a lifestyle disease. If you correct the lifestyle, your hormones should be under control. We explain to patients what's causing the imbalance rather than putting them on hormonal pills upfront, and give them 3 to 4 months to work on diet, exercise, stress management and sleep, alongside antioxidant medications. 60 to 70 percent of our patients come back at the end of 3 months saying they're having regular cycles.

Fertility-sparing treatment is done only if the lady desires fertility, the disease is early, confined to one single ovary, with no peritoneal deposits and no malignant cells in the ascites. Even at stage 1B we'd do a diagnostic laparoscopy to check the other ovary, because imaging might miss small deposits. For germ cell tumours we always do fertility-sparing surgery because they're highly chemosensitive; for other tumours the decision has to be tailor-made.

If it's an advanced stage, stage 3 or 4, treatment is usually chemotherapy with radiation therapy. Squamous cell carcinomas are radiosensitive, and chemotherapy is given as a radiosensitiser to get a better response. If there's stage 4 disease with distant metastasis, systemic therapy is needed. Even after this, if there's residual disease and the patient's performance status is good, we'd still go back and remove the residual disease.

We use ICG dye and do the procedure robotically or laparoscopically with a 4K camera using the Firefly technique. We always open the retroperitoneal spaces first and get everything ready before injecting, because if there's bleeding during dissection after injecting, you won't be able to locate the sentinel node properly. If you're implementing this for the first time, do a pilot study of at least 25 cases each for endometrial and cervical cancer before using it as your standard method.

In 64 percent of cases, the fallopian tube, not the ovary itself, is the source of the abnormal cell that seeds ovarian cancer, which is why tubal ligation reduces risk by roughly the same 64 percent.

It's the removal of the fallopian tubes during an unrelated procedure, like a myomectomy or hysterectomy, in a woman who doesn't want future fertility. It adds negligible risk to a case already underway while meaningfully lowering future ovarian cancer risk.

It holds that nulliparity, early menarche, and late menopause all add up to more lifetime ovulation cycles, and each cycle's wear and repair carries a small chance of a mutation taking hold.

Yes. Oral contraceptive use for more than five years cuts ovarian cancer risk by 50 percent, for the same reason as tubal ligation: fewer ovulation cycles over a lifetime.